*Institute of Medical Immunology
†Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle (Saale)
‡Department of Good Manufacturing Practice (GMP) Development & Advanced Therapy Medicinal Products (ATMP) Design, Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, GermanyLeipzig, Germany
§Institute for Translational Immunology, Medical School “Theodor Fontane”, Brandenburg, Germany
This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, 496182670), Jackstädt Foundation, Monika Kutzner Foundation), the Mildred Scheel Foundation, and the Sander Stiftung.
The authors have no conflicts of interest to disclose.
Reprints: Barbara Seliger, PhD, Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Magdeburger Street 2, Halle 06112, Germany (email: [email protected]).